Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 8/20 | 0.47 |
| ▸ | TOP2A | P11388 | 2/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | ACMSD | Q8TDX5 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31053414 | 0.79 | MEN1 (0.53) | DAOACMSDALDH1A1HTTRAB9A | |
| SCHEMBL23852226 | 0.79 | MEN1 (0.53) | DAOACMSDALDH1A1HTTRAB9A | |
| SCHEMBL32688002 | 0.79 | ACMSD (0.70) | CTSBTOP2AACMSDHTTRAB9A | |
| SCHEMBL24087928 | 0.77 | MEN1 (0.55) | DAOACMSDALDH1A1TSHRGFER | |
| SCHEMBL29976051 | 0.77 | MEN1 (0.55) | DAOACMSDALDH1A1TSHRGFER | |
| SCHEMBL32688381 | 0.76 | MEN1 (0.49) | CTSBACMSDALDH1A1HTT | |
| SCHEMBL32688027 | 0.74 | MEN1 (0.66) | CTSBTOP2AACMSDNPC1RAB9A | |
| SCHEMBL20340181 | 0.71 | KMT2A (0.42) | CTSBDAOACMSDALDH1A1MAPT | |
| SCHEMBL20340099 | 0.71 | KMT2A (0.40) | CTSBDAOACMSDALDH1A1MAPT | |
| SCHEMBL6963004 | 0.71 | MAOA (0.41) | DAONPC1RAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | CTSB 1942/4885TOP2A 1761/4885DAO 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.